{"entity":{"type":"insider","cik":"0001392459","url":"/insider/0001392459","json_url":"/insider/0001392459.json","name":"Campanelli Paul","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":120,"n_filings":10,"first":"2007-10-03","last":"2017-08-15","span_basis":"filed_date"},"name_variants":[{"name":"Campanelli Paul","source":"filing","n_filings":10,"first_seen":"2007-10-03","last_seen":"2017-08-15"}],"transactions":[{"id":4832531,"accession":"0001209191-17-048879","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-048879","line_url":"/filing/0001209191-17-048879#line-1","is_derivative":false,"issuer_cik":"0001392459","issuer_name":"Endo International plc","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001392459","owner_cik":"0001392459","owner_name":"Campanelli Paul","owner_display_name":"Campanelli Paul","owner_url":"/insider/0001392459","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":7.71,"price_display":"7.71","price_state":"stated","total_value":50115.0,"total_display":"50,115.00","total_whole":"50,115","shares_owned_after":213620.0,"shares_owned_after_display":"213,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-14","filed_date":"2017-08-15","scope":"insider"},{"id":5201473,"accession":"0001209191-17-021162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-021162","line_url":"/filing/0001209191-17-021162#line-1","is_derivative":false,"issuer_cik":"0001392459","issuer_name":"Endo International plc","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001392459","owner_cik":"0001392459","owner_name":"Campanelli Paul","owner_display_name":"Campanelli Paul","owner_url":"/insider/0001392459","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300.0,"shares_display":"2,300","price_per_share":10.72,"price_display":"10.72","price_state":"stated","total_value":24656.0,"total_display":"24,656.00","total_whole":"24,656","shares_owned_after":207120.0,"shares_owned_after_display":"207,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-16","filed_date":"2017-03-16","scope":"insider"},{"id":2413546,"accession":"0001209191-16-119062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-119062","line_url":"/filing/0001209191-16-119062#line-1","is_derivative":false,"issuer_cik":"0001392459","issuer_name":"Endo International plc","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001392459","owner_cik":"0001392459","owner_name":"Campanelli Paul","owner_display_name":"Campanelli Paul","owner_url":"/insider/0001392459","role":"Officer (Group President, Generics)","role_mark":"O","role_mark_label":"Officer (Group President, Generics)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group President, Generics","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13000.0,"shares_display":"13,000","price_per_share":15.53,"price_display":"15.53","price_state":"stated","total_value":201890.0,"total_display":"201,890.00","total_whole":"201,890","shares_owned_after":201069.0,"shares_owned_after_display":"201,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-10","filed_date":"2016-05-11","scope":"insider"},{"id":8346743,"accession":"0001209191-15-079481","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-079481","line_url":"/filing/0001209191-15-079481","is_derivative":false,"issuer_cik":"0001392459","issuer_name":"Endo International plc","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001392459","owner_cik":"0001392459","owner_name":"Campanelli Paul","owner_display_name":"Campanelli Paul","owner_url":"/insider/0001392459","role":"Officer (President, Par Pharmaceutical)","role_mark":"O","role_mark_label":"Officer (President, Par Pharmaceutical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Par Pharmaceutical","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":55.69238095238095,"price_display":"55.69","price_state":"stated","total_value":116954.0,"total_display":"116,954.00","total_whole":"116,954","shares_owned_after":187869.0,"shares_owned_after_display":"187,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-11","filed_date":"2015-11-12","scope":"insider","n_lines":2},{"id":9146465,"accession":"0000878088-11-000032","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0000878088-11-000032","line_url":"/filing/0000878088-11-000032","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001392459","owner_name":"Campanelli Paul","owner_display_name":"Campanelli Paul","owner_url":"/insider/0001392459","role":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark":"O","role_mark_label":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres-Par Pharmaceutical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4350.0,"shares_display":"4,350","price_per_share":30.51448275862069,"price_display":"30.51","price_state":"stated","total_value":132738.0,"total_display":"132,738.00","total_whole":"132,738","shares_owned_after":109062.0,"shares_owned_after_display":"109,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-08","filed_date":"2011-03-09","scope":"insider","n_lines":11},{"id":8935384,"accession":"0000878088-11-000033","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0000878088-11-000033","line_url":"/filing/0000878088-11-000033","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001392459","owner_name":"Campanelli Paul","owner_display_name":"Campanelli Paul","owner_url":"/insider/0001392459","role":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark":"O","role_mark_label":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres-Par Pharmaceutical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47720.0,"shares_display":"47,720","price_per_share":30.72918307627829,"price_display":"30.73","price_state":"stated","total_value":1466396.6164,"total_display":"1,466,396.62","total_whole":"1,466,397","shares_owned_after":68831.0,"shares_owned_after_display":"68,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-08","filed_date":"2011-03-09","scope":"insider","n_lines":29},{"id":9156159,"accession":"0000878088-11-000031","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0000878088-11-000031","line_url":"/filing/0000878088-11-000031#line-30","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001392459","owner_name":"Campanelli Paul","owner_display_name":"Campanelli Paul","owner_url":"/insider/0001392459","role":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark":"O","role_mark_label":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres-Par Pharmaceutical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75400.0,"shares_display":"75,400","price_per_share":30.75,"price_display":"30.75","price_state":"stated","total_value":2318550.0,"total_display":"2,318,550.00","total_whole":"2,318,550","shares_owned_after":148831.0,"shares_owned_after_display":"148,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-07","filed_date":"2011-03-09","scope":"insider"},{"id":9156158,"accession":"0000878088-11-000031","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0000878088-11-000031","line_url":"/filing/0000878088-11-000031#line-29","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001392459","owner_name":"Campanelli Paul","owner_display_name":"Campanelli Paul","owner_url":"/insider/0001392459","role":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark":"O","role_mark_label":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres-Par Pharmaceutical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":30.76,"price_display":"30.76","price_state":"stated","total_value":138420.0,"total_display":"138,420.00","total_whole":"138,420","shares_owned_after":142031.0,"shares_owned_after_display":"142,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-07","filed_date":"2011-03-09","scope":"insider"},{"id":9156157,"accession":"0000878088-11-000031","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0000878088-11-000031","line_url":"/filing/0000878088-11-000031#line-28","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001392459","owner_name":"Campanelli Paul","owner_display_name":"Campanelli Paul","owner_url":"/insider/0001392459","role":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark":"O","role_mark_label":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres-Par Pharmaceutical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3601.0,"shares_display":"3,601","price_per_share":30.765,"price_display":"30.76","price_state":"stated","total_value":110784.765,"total_display":"110,784.76","total_whole":"110,785","shares_owned_after":137730.0,"shares_owned_after_display":"137,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-07","filed_date":"2011-03-09","scope":"insider"},{"id":9156156,"accession":"0000878088-11-000031","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0000878088-11-000031","line_url":"/filing/0000878088-11-000031#line-27","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001392459","owner_name":"Campanelli Paul","owner_display_name":"Campanelli Paul","owner_url":"/insider/0001392459","role":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark":"O","role_mark_label":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres-Par Pharmaceutical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":30.81,"price_display":"30.81","price_state":"stated","total_value":70863.0,"total_display":"70,863.00","total_whole":"70,863","shares_owned_after":130030.0,"shares_owned_after_display":"130,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-07","filed_date":"2011-03-09","scope":"insider"},{"id":9156155,"accession":"0000878088-11-000031","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0000878088-11-000031","line_url":"/filing/0000878088-11-000031#line-26","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001392459","owner_name":"Campanelli Paul","owner_display_name":"Campanelli Paul","owner_url":"/insider/0001392459","role":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark":"O","role_mark_label":"Officer (EVP, Pres-Par Pharmaceutical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres-Par Pharmaceutical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":30.77,"price_display":"30.77","price_state":"stated","total_value":70771.0,"total_display":"70,771.00","total_whole":"70,771","shares_owned_after":135430.0,"shares_owned_after_display":"135,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-07","filed_date":"2011-03-09","scope":"insider"}],"collapsed":true,"next_cursor":"2011-03-07|9156155","ledger_fault":false,"count":{"value":120,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":114,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":120},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001593034","name":"Endo International plc","url":"/issuer/0001593034","role":"Director, Officer (President, CEO)","n_filings":4,"first_seen":"2015-11-12","last_seen":"2017-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000878088","name":"PAR PHARMACEUTICAL COMPANIES, INC.","url":"/issuer/0000878088","role":"Officer (EVP, Pres-Par Pharmaceutical)","n_filings":6,"first_seen":"2007-10-03","last_seen":"2011-03-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001392459","retrieved_at":"2026-08-26T06:12:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}